Related Experiment Video
Updated: Jan 25, 2026
16:09
Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice
Published on: October 4, 2014
17.0K
Systems Challenges of Hepatic Carcinomas: A Review
Dhatri Madduru1,2, Johny Ijaq3,2, Sujata Dhar2
1Department of Biochemistry, Osmania University, Hyderabad 500007, TG, India.
Journal of Clinical and Experimental Hepatology
|April 27, 2019
Summary
This review explores multi-omics approaches to understand Hepatocellular Carcinoma (HCC) progression. It highlights challenges in identifying key immunological, genetic, and epidemiological factors for this common liver cancer.
Area of Science:
- Oncology and Systems Biology
- Investigating complex diseases using multi-omics data.
Background:
- Hepatocellular Carcinoma (HCC) is a prevalent cancer, particularly in developing nations.
- Understanding HCC progression requires examining multifactorial influences like liver cirrhosis.
- Systems biology and multi-omics offer advanced methods for disease mechanism elucidation.
Purpose of the Study:
- To conduct a comprehensive review of multi-omics approaches for HCC research.
- To identify challenges in integrating multi-omics data for HCC factor analysis.
- To focus on immunological, genetic, and epidemiological contributors to HCC.
Main Methods:
- Comprehensive literature review of multi-omics studies related to HCC.
- Analysis of challenges in systems biology applications for cancer research.
- Synthesis of findings concerning immunological, genetic, and epidemiological factors.
Main Results:
- Multi-omics approaches provide extensive insights into HCC pathogenesis.
- Significant challenges exist in data integration and interpretation within multi-omics studies.
- Key factors influencing HCC include immunological, genetic, and epidemiological elements.
Conclusions:
- Multi-omics strategies are crucial for dissecting the complexity of Hepatocellular Carcinoma.
- Addressing challenges in multi-omics is essential for accurate identification of HCC drivers.
- Further research integrating diverse omics data can advance HCC prevention and treatment.
Keywords:
HBV, Hepatitis B VirusHCC, Hepatocellular CarcinomaHCV, Hepatitis B VirusNAFLD, Non-Alcoholic Fatty Liver Diseasehepatocellular carcinomaimmunomodulatorssignaling pathwayssystems biologyMore Related Videos
Related Concept Videos
01:10Review and Preview
8.3K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.3K
01:13Review and Preview
10.9K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
10.9K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
266
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
266
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
01:18Second Order systems II
396
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
396
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
221
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
221